Cataract Clinical Trial
Official title:
GALILEI G6 Lens Professional vs. a Predicate Device: a Comparison Study
Verified date | September 2018 |
Source | Ziemer Ophthalmic Systems AG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to compare the Ziemer Ophthalmic Systems AG GALILEI G6 Lens Professional to the Oculus Pentacam® AXL for taking images and measurements of the anterior segment of the eye, including the cornea, pupil, anterior chamber and lens, to assist in determining the power of the intraocular lens for implantation.
Status | Completed |
Enrollment | 112 |
Est. completion date | August 1, 2018 |
Est. primary completion date | August 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Satisfies one of the subject group categories and the enrollment quota for that category has not been reached: 1. Normal eyes (phakic eyes without cataracts or corneal disease, refraction = -5.5 D or = +5.0 D) 2. Eyes having undergone previous refractive surgery (LASIK or PRK) 3. Eyes with cataracts (LOCS III grading with grades 2-6 in any or all of the posterior subcapsular (P2-P5), nuclear (N2-N5) and cortical (C2-C5), assessed by slit lamp examination; no other known ocular pathology) 4. Eyes with severe myopia (= -6 D according to the American Academy of Ophthalmology) 5. Eyes with severe hyperopia (= +5.25 D according to the American Academy of Ophthalmology) 6. Eyes with previous cross-linking and eyes with advanced keratoconus - Manifest refraction sSpherical eEquivalent Refraction (MRSER) between -10dpt and +10dpt as measured by cycloplegic autorefraction assessed less than 12 months prior to enrollment - Best corrected visual acuity (BCVA) of LogMAR 0.2 or better Exclusion Criteria: - Strabismus, nystagmus, amblyopia, anisometropia (difference in MRSER>3D) - Angle closure glaucoma - Seizure disorder, brain damage, Down Syndrome, Trisomy 13 or 18, Cerebral Palsy or other serious ophthalmic or central nervous system disorders - Severe dry eye - Severe corneal scarring - Inability to hold gaze - Inability to see fixation target |
Country | Name | City | State |
---|---|---|---|
Switzerland | Ziemer Ophthalmic Systems AG | Port |
Lead Sponsor | Collaborator |
---|---|
Ziemer Ophthalmic Systems AG |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Axial Length (AL) Measurement in millimeters (mm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Central Corneal Thickness (CCT) Measurement in micrometers (µm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Radius Flat Meridian (R flat) Measurement in millimeters (mm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Radius Steep Meridian (R steep) Measurement in millimeters (mm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Mean Radius (Rm) Measurement in millimeters (mm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Corneal Cylinder Measurement in diopters (D) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Corneal Cylinder Axis (A flat) Measurement in degrees | Repeatability and reproducability across and between evaluations | One day | |
Primary | Anterior Chamber Depth (ACD) Measurement in millimeters (mm) | Repeatability and reproducability across and between evaluations | One day | |
Primary | Horizontal White-to-White distance (WtW) Measurement in millimeters (mm). | Repeatability and reproducability across and between evaluations | One day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |